Skip to content
6-K

Foreign Interim / Material

PSYENCE BIOMEDICAL LTD. PBM PBMWW

0001213900-25-113106

← back to feed
Filed
Nov 20, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2026 · Sep 30, 2025 1.48M sh
Shares Diluted Q2 2026 · Sep 30, 2025 1.06M sh
Shares Diluted restated Q2 2026 · Sep 30, 2024 34.72K sh
Shares Diluted restated Q2 2026 · Sep 30, 2024 28.95K sh
Operating Cash Flow Q2 2026 · Sep 30, 2025 −$2.03M
Operating Cash Flow Q2 2026 · Sep 30, 2024 −$1.52M
Cash And Equivalents Q2 2026 · Sep 30, 2025 $7.15M
Cash And Equivalents Q2 2026 · Mar 31, 2025 $6.14M
Cash And Equivalents Q2 2026 · Sep 30, 2024 $1.93M
Cash And Equivalents Q2 2026 · Mar 31, 2024 $733.19K
Stockholders Equity Q2 2026 · Sep 30, 2025 $11.87M
Stockholders Equity Q2 2026 · Mar 31, 2025 $6.72M
Stockholders Equity Q2 2026 · Sep 30, 2024 −$1.26M
Stockholders Equity Q2 2026 · Mar 31, 2024 −$10.97M
Total Liabilities Q2 2026 · Sep 30, 2025 $943.07K
Total Liabilities Q2 2026 · Mar 31, 2025 $594.37K
Current Assets Q2 2026 · Sep 30, 2025 $7.63M
Current Assets Q2 2026 · Mar 31, 2025 $6.56M
Total Assets Q2 2026 · Sep 30, 2025 $12.81M
Total Assets Q2 2026 · Mar 31, 2025 $7.32M
Eps Diluted Q2 2026 · Sep 30, 2025 −$0.51
Eps Diluted Q2 2026 · Sep 30, 2025 −$1.88
Eps Diluted restated Q2 2026 · Sep 30, 2024 $4.07
Eps Diluted restated Q2 2026 · Sep 30, 2024 $102.26
Eps Basic Q2 2026 · Sep 30, 2025 −$0.51
Eps Basic Q2 2026 · Sep 30, 2025 −$1.88
Eps Basic restated Q2 2026 · Sep 30, 2024 $4.07
Eps Basic restated Q2 2026 · Sep 30, 2024 $102.28
Rd Expense Q2 2026 · Sep 30, 2025 $357.44K
Rd Expense Q2 2026 · Sep 30, 2025 $672.36K
Rd Expense Q2 2026 · Sep 30, 2024 $265.63K
Rd Expense Q2 2026 · Sep 30, 2024 $265.63K
Net Income Q2 2026 · Sep 30, 2025 −$753.25K
Net Income Q2 2026 · Sep 30, 2025 −$1.99M
Net Income Q2 2026 · Sep 30, 2024 $141.47K
Net Income Q2 2026 · Sep 30, 2024 $2.96M